Fred Alger Management, LLC Aerie Pharmaceuticals Inc Transaction History

Fred Alger Management, LLC

$19.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$6.37 - $15.23 $2.94 Million - $7.02 Million	-461,240 Reduced 43.53%	598,325 $9.05 Million
Q2 2022 Aug 15, 2022	BUY	$4.95 - $9.16 $2.72 Million - $5.03 Million	549,357 Added 107.67%	1,059,565 $7.95 Million
Q1 2022 May 16, 2022	SELL	$5.64 - $9.8 $85,806 - $149,097	-15,214 Reduced 2.9%	510,208 $4.64 Million
Q4 2021 Feb 14, 2022	SELL	$7.02 - $13.33 $3.92 Million - $7.45 Million	-558,766 Reduced 51.54%	525,422 $3.69 Million
Q3 2021 Nov 15, 2021	BUY	$11.32 - $16.63 $198,847 - $292,122	17,566 Added 1.65%	1,084,188 $12.4 Million
Q2 2021 Aug 16, 2021	BUY	$15.16 - $18.97 $1.26 Million - $1.58 Million	83,257 Added 8.47%	1,066,622 $17.1 Million
Q1 2021 May 17, 2021	BUY	$13.12 - $20.9 $583,026 - $928,754	44,438 Added 4.73%	983,365 $17.6 Million
Q4 2020 Feb 16, 2021	BUY	$9.12 - $14.49 $153,963 - $244,620	16,882 Added 1.83%	938,927 $12.7 Million
Q3 2020 Nov 13, 2020	SELL	$10.46 - $14.46 $8.31 Million - $11.5 Million	-794,668 Reduced 46.29%	922,045 $10.9 Million
Q2 2020 Aug 14, 2020	BUY	$12.0 - $16.13 $3.84 Million - $5.16 Million	319,731 Added 22.89%	1,716,713 $25.3 Million
Q1 2020 May 15, 2020	BUY	$11.84 - $25.52 $3.86 Million - $8.32 Million	326,190 Added 30.46%	1,396,982 $18.9 Million
Q4 2019 Feb 14, 2020	BUY	$17.72 - $25.1 $10.3 Million - $14.5 Million	579,086 Added 117.77%	1,070,792 $25.9 Million
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $1.76 Million - $2.67 Million	95,389 Added 24.07%	491,706 $9.45 Million
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $3.49 Million - $5.82 Million	120,628 Added 43.76%	396,317 $11.7 Million
Q1 2019 May 14, 2019	BUY	$36.32 - $49.25 $4.64 Million - $6.29 Million	127,664 Added 86.24%	275,689 $13.1 Million
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $674,718 - $1.23 Million	-20,446 Reduced 12.14%	148,025 $5.34 Million
Q3 2018 Nov 14, 2018	SELL	$56.15 - $73.9 $845,619 - $1.11 Million	-15,060 Reduced 8.21%	168,471 $10.4 Million
Q2 2018 Jul 19, 2018	SELL	$47.85 - $70.45 $6.78 Million - $9.98 Million	-141,625 Reduced 43.56%	183,531 $12.4 Million
Q1 2018 May 10, 2018	SELL	$51.15 - $61.0 $756,355 - $902,007	-14,787 Reduced 4.35%	325,156 $17.6 Million
Q4 2017 Feb 14, 2018	SELL	$50.85 - $65.1 $628,658 - $804,831	-12,363 Reduced 3.51%	339,943 $20.3 Million
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $17.1 Million - $21.2 Million	352,306	352,306 $17.1 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account